Edward Lang
Corporate Officer/Principal en GYROSCOPE THERAPEUTICS HOLDINGS PLC .
Cargos activos de Edward Lang
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Corporate Officer/Principal | 01/06/2019 | - |
Historial de carrera de Edward Lang
Antiguos cargos conocidos de Edward Lang.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/12/2017 | 01/06/2018 |
Formación de Edward Lang.
| LaSalle University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Reino Unido | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Edward Lang
- Experiencia
